Endoscopic sclerotherapy for oesophageal varices. Current status in Nigeria.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001592:Benzyl Alcohols / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004932:Esophageal and Gastric Varices / Q000150:complications* / Q000473:pathology; D004945:Esophagoscopy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007454:Iodides / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D012964:Sodium / Q000627:therapeutic use*
D001592:Benzyl Alcohols; D001593:Benzyl Compounds; D004338:Drug Combinations; D007454:Iodides; D012597:Sclerosing Solutions; C053468:Varigloban; D012964:Sodium